Lindsay Rosenwald: A Primer on Influenza

1. Lindsay Rosenwald: A Primer on
Influenza

2. ● Influenza, caused by a virus, affects millions of people
each year, resulting in numerous instances of lost
productivity.
● The Centers for Disease Control and Prevention
estimate that anywhere from 5 to 20 percent of the
population of the United States contracts the disease
annually, resulting in hundreds of thousands of
hospitalizations due to complications that can be life-
threatening.
● Young children, seniors, pregnant women, and
individuals with lowered immune function are particularly
vulnerable to contracting influenza.

3. ● Influenza can last weeks longer than the
common cold, but does not produce the same
symptoms of diarrhea and vomiting.
● Influenza is specifically characterized by a
seemingly sudden onset, fever, headache,
body aches, a dry cough or sore throat,
lowered appetite, and fatigue.
● The virus can lead to bacterial infections of
the ears, sinuses, or bronchi in the lungs, and
in some cases to pneumonia.

4. ● A doctor is usually able to diagnose influenza
based on the results of a physical examination
alone.
● A blood test or an assay of fluid from the
throat or nose can provide additional
information about the particular flu strain an
individual has contracted.
● Several new varieties of the virus develop
each year.

5. ● Dr. Lindsay Rosenwald was among the first
physician-investors to become successful on
Wall Street.
● He has achieved a ranking among the list of
100 Molecular Millionaires published by
Genetic Engineering & Biotechnology News,
and has supported a variety of biotechnology
companies that have developed treatments for
influenza and numerous other diseases.
[Sources:
http://www.mayoclinic.com/health/influenza/DS00081
http://www.webmd.com/cold-and-flu/tc/influenza-topic-
overview
http://www.cdc.gov/flu/about/qa/disease.htm]

6. ● Dr. Lindsay Rosenwald was among the first
physician-investors to become successful on
Wall Street.
● He has achieved a ranking among the list of
100 Molecular Millionaires published by
Genetic Engineering & Biotechnology News,
and has supported a variety of biotechnology
companies that have developed treatments for
influenza and numerous other diseases.
[Sources:
http://www.mayoclinic.com/health/influenza/DS00081
http://www.webmd.com/cold-and-flu/tc/influenza-topic-
overview
http://www.cdc.gov/flu/about/qa/disease.htm]